Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32846 | heamatoxylon campechianum | Species | NA | NA | Stems | XiShuangBanNa, Yunnan Province, China | 2005-SEP |
PMID[18610999] |
NPO29935 | Caesalpinia sappan | Species | Fabaceae | Eukaryota | TCM_Taiwan* | |||
NPO29935 | Caesalpinia sappan | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO29935 | Caesalpinia sappan | Species | Fabaceae | Eukaryota | heartwood |
PMID[19420770] |
||
NPO2554 | Biancaea sappan | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO2554 | Biancaea sappan | Species | Fabaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | Inhibition | = | 33.3 | % | 18610999 |
NPT1478 | Individual Protein | Vascular endothelial growth factor receptor 2 | Homo sapiens | Inhibition | = | 83.5 | % | 18610999 |
NPT1479 | Individual Protein | Stem cell growth factor receptor | Homo sapiens | Inhibition | = | 44.7 | % | 18610999 |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | Inhibition | = | 26.7 | % | 18610999 |
NPT1480 | Individual Protein | Fibroblast growth factor receptor 1 | Homo sapiens | Inhibition | = | 86.9 | % | 18610999 |
NPT1481 | Individual Protein | Fibroblast growth factor receptor 2 | Homo sapiens | Inhibition | = | 48.5 | % | 18610999 |
NPT1337 | Individual Protein | Hepatocyte growth factor receptor | Homo sapiens | Inhibition | = | 64.3 | % | 18610999 |
NPT35 | Others | n.a. | Activity | = | 1.93 | MU | 19944611 | |
NPT2 | Others | Unspecified | Activity | = | 1.82 | MU | 19944611 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC301178 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC284556 |
0.9926 | High Similarity | NPC471417 |
0.9781 | High Similarity | NPC287722 |
0.9781 | High Similarity | NPC254659 |
0.971 | High Similarity | NPC142165 |
0.9638 | High Similarity | NPC119663 |
0.9635 | High Similarity | NPC110419 |
0.9574 | High Similarity | NPC254702 |
0.9574 | High Similarity | NPC194653 |
0.9574 | High Similarity | NPC80710 |
0.9574 | High Similarity | NPC139364 |
0.9574 | High Similarity | NPC203747 |
0.9568 | High Similarity | NPC242893 |
0.9568 | High Similarity | NPC38065 |
0.9565 | High Similarity | NPC312256 |
0.9507 | High Similarity | NPC264550 |
0.9507 | High Similarity | NPC92722 |
0.9507 | High Similarity | NPC200060 |
0.9507 | High Similarity | NPC40290 |
0.9507 | High Similarity | NPC195763 |
0.9507 | High Similarity | NPC38545 |
0.9507 | High Similarity | NPC171916 |
0.9507 | High Similarity | NPC264289 |
0.9507 | High Similarity | NPC142876 |
0.9507 | High Similarity | NPC102003 |
0.9507 | High Similarity | NPC333691 |
0.9507 | High Similarity | NPC69430 |
0.9507 | High Similarity | NPC139293 |
0.9504 | High Similarity | NPC95864 |
0.9504 | High Similarity | NPC108406 |
0.9485 | High Similarity | NPC472364 |
0.9485 | High Similarity | NPC473391 |
0.9441 | High Similarity | NPC472279 |
0.9441 | High Similarity | NPC10467 |
0.9441 | High Similarity | NPC85131 |
0.9437 | High Similarity | NPC238279 |
0.9437 | High Similarity | NPC131451 |
0.9437 | High Similarity | NPC166036 |
0.9437 | High Similarity | NPC287395 |
0.9437 | High Similarity | NPC183655 |
0.9437 | High Similarity | NPC15329 |
0.9437 | High Similarity | NPC203077 |
0.9433 | High Similarity | NPC12377 |
0.9429 | High Similarity | NPC207732 |
0.9429 | High Similarity | NPC105213 |
0.942 | High Similarity | NPC50823 |
0.9375 | High Similarity | NPC31363 |
0.9375 | High Similarity | NPC256406 |
0.9375 | High Similarity | NPC260895 |
0.9371 | High Similarity | NPC183950 |
0.9371 | High Similarity | NPC137062 |
0.9371 | High Similarity | NPC270465 |
0.9371 | High Similarity | NPC87125 |
0.9371 | High Similarity | NPC52005 |
0.9371 | High Similarity | NPC287101 |
0.9371 | High Similarity | NPC105512 |
0.9371 | High Similarity | NPC223579 |
0.9366 | High Similarity | NPC119660 |
0.9366 | High Similarity | NPC188074 |
0.9366 | High Similarity | NPC93034 |
0.9366 | High Similarity | NPC125449 |
0.9362 | High Similarity | NPC70136 |
0.9362 | High Similarity | NPC157133 |
0.9333 | High Similarity | NPC129132 |
0.9333 | High Similarity | NPC257756 |
0.9333 | High Similarity | NPC87231 |
0.9333 | High Similarity | NPC212631 |
0.9333 | High Similarity | NPC205468 |
0.931 | High Similarity | NPC39732 |
0.931 | High Similarity | NPC324233 |
0.931 | High Similarity | NPC35763 |
0.931 | High Similarity | NPC323626 |
0.931 | High Similarity | NPC257648 |
0.931 | High Similarity | NPC245382 |
0.931 | High Similarity | NPC100263 |
0.931 | High Similarity | NPC121522 |
0.931 | High Similarity | NPC55205 |
0.931 | High Similarity | NPC100971 |
0.931 | High Similarity | NPC216769 |
0.931 | High Similarity | NPC304954 |
0.931 | High Similarity | NPC131266 |
0.931 | High Similarity | NPC60972 |
0.931 | High Similarity | NPC209487 |
0.931 | High Similarity | NPC477231 |
0.931 | High Similarity | NPC269451 |
0.931 | High Similarity | NPC181209 |
0.931 | High Similarity | NPC291802 |
0.9306 | High Similarity | NPC188871 |
0.9306 | High Similarity | NPC184136 |
0.9306 | High Similarity | NPC286342 |
0.9306 | High Similarity | NPC29231 |
0.9306 | High Similarity | NPC149127 |
0.9301 | High Similarity | NPC218490 |
0.9301 | High Similarity | NPC3036 |
0.9301 | High Similarity | NPC119059 |
0.9301 | High Similarity | NPC120464 |
0.9296 | High Similarity | NPC165389 |
0.9291 | High Similarity | NPC279121 |
0.9275 | High Similarity | NPC44573 |
0.9265 | High Similarity | NPC472365 |
0.9265 | High Similarity | NPC312318 |
0.9265 | High Similarity | NPC188646 |
0.9265 | High Similarity | NPC242294 |
0.9265 | High Similarity | NPC56031 |
0.9265 | High Similarity | NPC175098 |
0.9265 | High Similarity | NPC263670 |
0.9265 | High Similarity | NPC192304 |
0.9265 | High Similarity | NPC139813 |
0.9265 | High Similarity | NPC337373 |
0.9259 | High Similarity | NPC308037 |
0.9259 | High Similarity | NPC64359 |
0.9259 | High Similarity | NPC262359 |
0.9247 | High Similarity | NPC469550 |
0.9247 | High Similarity | NPC124714 |
0.9241 | High Similarity | NPC252933 |
0.9241 | High Similarity | NPC154345 |
0.9241 | High Similarity | NPC45291 |
0.9241 | High Similarity | NPC200740 |
0.9241 | High Similarity | NPC19980 |
0.9241 | High Similarity | NPC54394 |
0.9241 | High Similarity | NPC125062 |
0.9236 | High Similarity | NPC1612 |
0.9236 | High Similarity | NPC183959 |
0.9236 | High Similarity | NPC177298 |
0.9236 | High Similarity | NPC48479 |
0.9231 | High Similarity | NPC12200 |
0.9231 | High Similarity | NPC168803 |
0.9231 | High Similarity | NPC74881 |
0.9231 | High Similarity | NPC86847 |
0.9231 | High Similarity | NPC51443 |
0.9231 | High Similarity | NPC140840 |
0.922 | High Similarity | NPC175013 |
0.9197 | High Similarity | NPC286336 |
0.9184 | High Similarity | NPC117992 |
0.9184 | High Similarity | NPC230149 |
0.9184 | High Similarity | NPC234255 |
0.9184 | High Similarity | NPC152951 |
0.9184 | High Similarity | NPC256612 |
0.9184 | High Similarity | NPC168247 |
0.9184 | High Similarity | NPC39184 |
0.9184 | High Similarity | NPC57674 |
0.9184 | High Similarity | NPC20830 |
0.9184 | High Similarity | NPC38898 |
0.9184 | High Similarity | NPC2928 |
0.9178 | High Similarity | NPC222830 |
0.9178 | High Similarity | NPC239128 |
0.9178 | High Similarity | NPC293183 |
0.9178 | High Similarity | NPC187498 |
0.9178 | High Similarity | NPC219582 |
0.9178 | High Similarity | NPC162313 |
0.9178 | High Similarity | NPC236637 |
0.9178 | High Similarity | NPC260979 |
0.9178 | High Similarity | NPC156222 |
0.9178 | High Similarity | NPC83508 |
0.9178 | High Similarity | NPC302950 |
0.9178 | High Similarity | NPC275836 |
0.9178 | High Similarity | NPC301323 |
0.9178 | High Similarity | NPC198826 |
0.9178 | High Similarity | NPC82325 |
0.9178 | High Similarity | NPC212678 |
0.9178 | High Similarity | NPC279989 |
0.9178 | High Similarity | NPC241498 |
0.9178 | High Similarity | NPC275722 |
0.9178 | High Similarity | NPC57030 |
0.9178 | High Similarity | NPC120163 |
0.9178 | High Similarity | NPC131624 |
0.9178 | High Similarity | NPC25270 |
0.9178 | High Similarity | NPC100887 |
0.9178 | High Similarity | NPC256283 |
0.9178 | High Similarity | NPC71334 |
0.9178 | High Similarity | NPC188203 |
0.9178 | High Similarity | NPC472912 |
0.9172 | High Similarity | NPC62042 |
0.9172 | High Similarity | NPC156953 |
0.9172 | High Similarity | NPC3825 |
0.9172 | High Similarity | NPC88804 |
0.9167 | High Similarity | NPC474903 |
0.9167 | High Similarity | NPC294852 |
0.9167 | High Similarity | NPC43669 |
0.9167 | High Similarity | NPC12367 |
0.9167 | High Similarity | NPC188679 |
0.9167 | High Similarity | NPC272721 |
0.9167 | High Similarity | NPC195202 |
0.9167 | High Similarity | NPC118726 |
0.9167 | High Similarity | NPC19545 |
0.9167 | High Similarity | NPC196277 |
0.9167 | High Similarity | NPC321011 |
0.9161 | High Similarity | NPC143903 |
0.9161 | High Similarity | NPC179271 |
0.9161 | High Similarity | NPC138978 |
0.9161 | High Similarity | NPC20791 |
0.9161 | High Similarity | NPC226987 |
0.9149 | High Similarity | NPC299154 |
0.9149 | High Similarity | NPC49108 |
0.9143 | High Similarity | NPC109232 |
0.9137 | High Similarity | NPC7013 |
0.9137 | High Similarity | NPC116632 |
0.9137 | High Similarity | NPC209560 |
0.9137 | High Similarity | NPC162680 |
0.9137 | High Similarity | NPC303644 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC301178 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9291 | High Similarity | NPD1511 | Approved |
0.9178 | High Similarity | NPD1934 | Approved |
0.9161 | High Similarity | NPD1512 | Approved |
0.9122 | High Similarity | NPD3882 | Suspended |
0.9118 | High Similarity | NPD1240 | Approved |
0.9116 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.9116 | High Similarity | NPD2801 | Approved |
0.8993 | High Similarity | NPD1510 | Phase 2 |
0.8986 | High Similarity | NPD1607 | Approved |
0.8978 | High Similarity | NPD943 | Approved |
0.8671 | High Similarity | NPD1549 | Phase 2 |
0.8601 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8601 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.859 | High Similarity | NPD6166 | Phase 2 |
0.859 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.859 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD3817 | Phase 2 |
0.8542 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8533 | High Similarity | NPD4380 | Phase 2 |
0.8503 | High Similarity | NPD6799 | Approved |
0.8481 | Intermediate Similarity | NPD3818 | Discontinued |
0.8428 | Intermediate Similarity | NPD7054 | Approved |
0.8403 | Intermediate Similarity | NPD2796 | Approved |
0.838 | Intermediate Similarity | NPD230 | Phase 1 |
0.8377 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8375 | Intermediate Similarity | NPD7472 | Approved |
0.8375 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8344 | Intermediate Similarity | NPD6232 | Discontinued |
0.8333 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8323 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8323 | Intermediate Similarity | NPD7075 | Discontinued |
0.8322 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8302 | Intermediate Similarity | NPD7473 | Discontinued |
0.8276 | Intermediate Similarity | NPD2935 | Discontinued |
0.8272 | Intermediate Similarity | NPD7251 | Discontinued |
0.8247 | Intermediate Similarity | NPD7819 | Suspended |
0.8247 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8205 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.817 | Intermediate Similarity | NPD6599 | Discontinued |
0.8151 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8117 | Intermediate Similarity | NPD7411 | Suspended |
0.811 | Intermediate Similarity | NPD7808 | Phase 3 |
0.811 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8101 | Intermediate Similarity | NPD5494 | Approved |
0.8092 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8085 | Intermediate Similarity | NPD9494 | Approved |
0.8077 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8065 | Intermediate Similarity | NPD6801 | Discontinued |
0.8058 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.8054 | Intermediate Similarity | NPD3750 | Approved |
0.8013 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7972 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7959 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.795 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7945 | Intermediate Similarity | NPD6651 | Approved |
0.7925 | Intermediate Similarity | NPD919 | Approved |
0.7917 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7902 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7879 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD447 | Suspended |
0.7867 | Intermediate Similarity | NPD2800 | Approved |
0.7862 | Intermediate Similarity | NPD3749 | Approved |
0.7857 | Intermediate Similarity | NPD5403 | Approved |
0.7857 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7852 | Intermediate Similarity | NPD2344 | Approved |
0.7848 | Intermediate Similarity | NPD5402 | Approved |
0.7843 | Intermediate Similarity | NPD5401 | Approved |
0.7843 | Intermediate Similarity | NPD2533 | Approved |
0.7843 | Intermediate Similarity | NPD2532 | Approved |
0.7843 | Intermediate Similarity | NPD2534 | Approved |
0.7832 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD1247 | Approved |
0.7826 | Intermediate Similarity | NPD6959 | Discontinued |
0.7817 | Intermediate Similarity | NPD1203 | Approved |
0.7808 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7808 | Intermediate Similarity | NPD1613 | Approved |
0.7799 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7791 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7758 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7758 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7748 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7748 | Intermediate Similarity | NPD1243 | Approved |
0.7725 | Intermediate Similarity | NPD6559 | Discontinued |
0.7718 | Intermediate Similarity | NPD3748 | Approved |
0.7697 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7662 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD2309 | Approved |
0.7639 | Intermediate Similarity | NPD2798 | Approved |
0.7635 | Intermediate Similarity | NPD1933 | Approved |
0.7632 | Intermediate Similarity | NPD2654 | Approved |
0.7628 | Intermediate Similarity | NPD920 | Approved |
0.7609 | Intermediate Similarity | NPD9493 | Approved |
0.7606 | Intermediate Similarity | NPD9717 | Approved |
0.76 | Intermediate Similarity | NPD2799 | Discontinued |
0.7597 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD9268 | Approved |
0.756 | Intermediate Similarity | NPD5953 | Discontinued |
0.7554 | Intermediate Similarity | NPD5536 | Phase 2 |
0.755 | Intermediate Similarity | NPD6099 | Approved |
0.755 | Intermediate Similarity | NPD6100 | Approved |
0.7548 | Intermediate Similarity | NPD7390 | Discontinued |
0.7534 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7532 | Intermediate Similarity | NPD3226 | Approved |
0.7532 | Intermediate Similarity | NPD6190 | Approved |
0.7517 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD9545 | Approved |
0.75 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3972 | Approved |
0.7466 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7448 | Intermediate Similarity | NPD1470 | Approved |
0.744 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7436 | Intermediate Similarity | NPD4357 | Discontinued |
0.7432 | Intermediate Similarity | NPD411 | Approved |
0.7432 | Intermediate Similarity | NPD2313 | Discontinued |
0.7414 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7413 | Intermediate Similarity | NPD422 | Phase 1 |
0.7413 | Intermediate Similarity | NPD1201 | Approved |
0.7413 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7386 | Intermediate Similarity | NPD2346 | Discontinued |
0.7381 | Intermediate Similarity | NPD3751 | Discontinued |
0.7378 | Intermediate Similarity | NPD6234 | Discontinued |
0.7376 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7372 | Intermediate Similarity | NPD228 | Approved |
0.7368 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD1608 | Approved |
0.7355 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD2982 | Phase 2 |
0.731 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7305 | Intermediate Similarity | NPD5242 | Approved |
0.7305 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7292 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7284 | Intermediate Similarity | NPD37 | Approved |
0.7278 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD1876 | Approved |
0.7255 | Intermediate Similarity | NPD4308 | Phase 3 |
0.725 | Intermediate Similarity | NPD1653 | Approved |
0.7246 | Intermediate Similarity | NPD5711 | Approved |
0.7246 | Intermediate Similarity | NPD5710 | Approved |
0.7241 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7234 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD6385 | Approved |
0.7222 | Intermediate Similarity | NPD6386 | Approved |
0.7211 | Intermediate Similarity | NPD1164 | Approved |
0.7209 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7208 | Intermediate Similarity | NPD5406 | Approved |
0.7208 | Intermediate Similarity | NPD5408 | Approved |
0.7208 | Intermediate Similarity | NPD5405 | Approved |
0.7208 | Intermediate Similarity | NPD5404 | Approved |
0.7205 | Intermediate Similarity | NPD7458 | Discontinued |
0.72 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD3268 | Approved |
0.72 | Intermediate Similarity | NPD3764 | Approved |
0.7195 | Intermediate Similarity | NPD5353 | Approved |
0.7153 | Intermediate Similarity | NPD17 | Approved |
0.7152 | Intermediate Similarity | NPD4965 | Approved |
0.7152 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7152 | Intermediate Similarity | NPD4966 | Approved |
0.7143 | Intermediate Similarity | NPD3787 | Discontinued |
0.7143 | Intermediate Similarity | NPD7033 | Discontinued |
0.7143 | Intermediate Similarity | NPD1241 | Discontinued |
0.7143 | Intermediate Similarity | NPD3225 | Approved |
0.7099 | Intermediate Similarity | NPD3455 | Phase 2 |
0.7095 | Intermediate Similarity | NPD2797 | Approved |
0.7091 | Intermediate Similarity | NPD4288 | Approved |
0.7091 | Intermediate Similarity | NPD2296 | Approved |
0.7089 | Intermediate Similarity | NPD2354 | Approved |
0.7076 | Intermediate Similarity | NPD7228 | Approved |
0.7072 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD7266 | Discontinued |
0.7051 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7047 | Intermediate Similarity | NPD1019 | Discontinued |
0.7029 | Intermediate Similarity | NPD9266 | Approved |
0.7029 | Intermediate Similarity | NPD74 | Approved |
0.7027 | Intermediate Similarity | NPD1283 | Approved |
0.7025 | Intermediate Similarity | NPD7003 | Approved |
0.7025 | Intermediate Similarity | NPD8166 | Discontinued |
0.7021 | Intermediate Similarity | NPD5283 | Phase 1 |
0.702 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7006 | Intermediate Similarity | NPD6971 | Discontinued |
0.6994 | Remote Similarity | NPD824 | Approved |
0.6994 | Remote Similarity | NPD1729 | Discontinued |
0.6993 | Remote Similarity | NPD4307 | Phase 2 |
0.698 | Remote Similarity | NPD3266 | Approved |
0.698 | Remote Similarity | NPD3267 | Approved |
0.6978 | Remote Similarity | NPD3021 | Approved |
0.6978 | Remote Similarity | NPD3022 | Approved |
0.6974 | Remote Similarity | NPD6798 | Discontinued |
0.6974 | Remote Similarity | NPD1296 | Phase 2 |
0.697 | Remote Similarity | NPD6844 | Discontinued |
0.6966 | Remote Similarity | NPD1651 | Approved |
0.6961 | Remote Similarity | NPD4363 | Phase 3 |
0.6961 | Remote Similarity | NPD4360 | Phase 2 |
PubChem CID   | 5319493 |
ChEMBL   | CHEMBL476986 |
ZINC   |
Molecular Weight:   | 286.08 |
ALogP:   | -1.3354 |
MLogP:   | 2.67 |
XLogP:   | 2.109 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 21 |